Novo Nordisk A/S (NVO) Stock Forecast & Price Target

NVO price $38.16 -0.51 -1.32%

Ticker
NVO
Price
$38.16
Change
-0.51 -1.32%
Market cap ?
$168.36B
Sector
Healthcare
Industry
Drug Manufacturers - General

Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business…

Fair value

NVO fair value $434.38. Price $38.16. Price is 91% below fair value.

Below fair value, and cheaper than usual. A larger discount than on 79% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 97.12B. Growth 8.04%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 4.41B. Net debt 104.49B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Free cash flow adds back growth capex above depreciation.

Compare NVO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—0.73—11.09B
2026-08-050.960.8212.13B10.89B
2026-05-061.040.8711.02B10.86B
2026-02-031.000.9012.50B12.13B
2025-11-051.020.7711.53B11.94B
2025-08-060.970.9311.97B11.92B
2025-05-070.920.9211.90B11.70B
2025-02-050.910.8811.86B11.55B
2024-11-060.880.8710.68B10.48B
2024-08-070.660.709.80B10.04B
2024-05-020.820.749.38B9.07B
2024-01-310.710.669.60B9.15B
2023-11-020.730.698.35B8.17B
2023-08-100.630.678.03B8.21B
2023-05-040.630.637.88B7.66B
2023-02-010.410.416.93B6.84B
2022-11-020.430.426.04B5.89B
2022-08-030.420.445.62B5.73B
2022-04-290.470.435.96B5.77B
2022-02-020.370.355.82B5.76B
2021-11-030.420.405.56B842.24M
2021-08-040.430.385.27B5.09B
2021-05-050.440.405.34B5.12B
2021-02-030.320.295.28B5.11B
2020-10-300.340.344.87B4.96B
2020-08-060.340.324.53B5.19B
2020-05-060.380.374.93B3.94B
2020-02-050.280.284.92B4.75B
2019-11-010.320.314.44B4.36B
2019-08-200.310.314.56B4.46B
2019-05-030.330.314.40B4.10B
2019-02-010.270.284.77B4.80B
2018-11-010.290.294.34B4.44B
2018-08-080.340.324.27B4.04B
2018-05-020.370.344.45B4.07B
2018-02-010.260.284.41B5.08B
2017-11-010.310.294.21B4.02B
2017-08-100.290.284.39B4.60B
2017-05-030.290.264.10B3.79B
2017-02-020.250.264.17B4.19B

Dividends

Yield 4.71%. Payout ratio 44.64%. Frequency Semi-Annual.

Safety score 95/100 · Safe. Payout ratio is 45% of earnings. Dividends use less than 40% of free cash flow. Dividends were paid in 42 separate years. Yield is 4.7%, in a range that is usually sustainable.

Ex-dateDividendRecordPaymentFrequency
2026-08-17$0.582026-08-172026-08-25Semi-Annual
2026-03-30$1.222026-03-302026-04-08Semi-Annual
2025-08-18$0.582025-08-182025-08-26Semi-Annual
2025-03-31$1.142025-03-312025-04-08Semi-Annual
2024-08-16$0.522024-08-162024-08-26Semi-Annual
2024-03-22$0.932024-03-252024-04-02Semi-Annual
2023-08-18$0.442023-08-212023-08-29Semi-Annual
2023-03-24$0.592023-03-272023-04-04Semi-Annual
2022-08-12$0.292022-08-152022-08-23Semi-Annual
2022-03-25$0.512022-03-282022-04-05Semi-Annual
2021-08-16$0.282021-08-172021-08-25Semi-Annual
2021-03-26$0.462021-03-292021-04-07Semi-Annual
2020-08-14$0.262020-08-172020-08-25Semi-Annual
2020-03-27$0.392020-03-302020-04-07Semi-Annual
2019-08-16$0.222019-08-192019-08-27Semi-Annual
2019-03-22$0.392019-03-252019-04-02Semi-Annual
2018-08-17$0.232018-08-202018-08-28Semi-Annual
2018-03-23$0.402018-03-262018-04-03Semi-Annual
2017-08-17$0.242017-08-212017-08-29Semi-Annual
2017-03-23$0.342017-03-272017-04-04Semi-Annual
2016-08-11$0.232016-08-152016-08-23Semi-Annual
2016-03-18$0.482016-03-222016-03-30Annual
2015-03-19$0.362015-03-232015-03-31Annual
2014-03-21$0.422014-03-252014-04-02Annual
2013-03-21$0.312013-03-252013-04-02Annual
2012-03-22$0.252012-03-262012-04-03Annual
2011-03-24$0.192011-03-282011-04-05Annual
2010-03-25$0.142010-03-292010-04-07Annual
2009-03-19$0.112009-03-232009-03-31Annual
2008-03-13$0.092008-03-172008-03-25Annual
2007-03-08$0.062007-03-122007-03-20Annual
2006-03-09$0.052006-03-132006-03-21Annual
2005-03-10$0.042005-03-142005-03-22Annual
2004-03-17$0.042004-03-192004-03-29Annual
2003-03-26$0.032003-03-282003-04-07Annual
2002-03-13$0.022002-03-152002-03-25Annual
2001-03-21$0.022001-03-232001-04-02Annual
2000-03-24$0.012000-03-282000-04-06Annual
1999-03-25$0.011999-03-291999-04-06Annual
1998-03-27$0.011998-03-311998-04-08Annual
1997-04-25$0.011997-04-291997-05-07Annual
1996-05-01$0.001996-05-031996-05-14Annual
1995-04-24$0.001995-04-281995-05-16Annual
1994-04-26$0.001994-05-021994-05-18Annual
1993-04-22$0.001993-04-281993-05-13Annual
1992-04-28$0.001992-05-041992-05-20Annual
1991-04-19$0.001991-04-251991-05-10Annual
1990-04-23$0.001990-04-271990-05-15Annual
1989-04-21$0.001989-04-271989-05-12Annual
1988-04-21$0.001988-04-271988-05-12Annual
1987-04-20$0.001987-04-241987-05-11Annual
1986-04-21$0.001986-04-251986-05-12Annual
1985-04-19$0.001985-04-251985-05-10Annual

Insider trades

DateInsiderActionSharesPriceValue
No data yet.

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 1.46K, holders +84 vs prior quarter. Ownership 7.41%.

HolderSharesChangeChange %Value
DODGE & COX20.40M1.06M+5.50%977.84M
LOOMIS SAYLES & CO L P18.59M1.58M+9.27%891.41M
FRANKLIN TEMPLETON INC13.04M-3.04M-18.92%625.19M
SUSQUEHANNA INTERNATIONAL GROUP, LLP12.01M7.41M+161.13%575.72M
PRICE T ROWE ASSOCIATES INC /MD/11.70M644.04K+5.82%561.12M
MORGAN STANLEY11.66M790.67K+7.27%558.97M
BANK OF AMERICA CORP /DE/11.18M407.01K+3.78%535.81M
CAPITAL INTERNATIONAL INVESTORS9.72M-2.07M-17.59%467.58M
FOLKETRYGDFONDET9.52M441.56K+4.86%456.50M
GOLDMAN SACHS GROUP INC9.18M4.06M+79.27%440.11M
CITADEL ADVISORS LLC9.06M6.32M+231.05%434.31M
CITADEL ADVISORS LLC8.83M6.09M+222.72%423.38M
SUSQUEHANNA INTERNATIONAL GROUP, LLP8.83M4.23M+92.01%423.32M
FISHER ASSET MANAGEMENT, LLC8.32M-696.15K-7.72%399.10M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP8.27M443.29K+5.66%396.50M
JANE STREET GROUP, LLC7.28M5.26M+259.91%349.22M
EVERETT HARRIS & CO /CA/6.48M50.96K+0.79%310.44M
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO6.14M00.00%294.48M
STATE STREET CORP5.87M32.64K+0.56%284.57M
ROYAL BANK OF CANADA5.40M871.28K+19.24%258.83M
CAPITAL WORLD INVESTORS5.21M-3.50K-0.07%249.61M
D. E. SHAW & CO., INC.5.09M3.66M+255.71%243.87M
FRED ALGER MANAGEMENT, LLC4.91M4.91MNew235.27M
SUSQUEHANNA INTERNATIONAL GROUP, LLP4.82M216.68K+4.71%230.86M
WELLS FARGO & COMPANY/MN4.66M1.02M+27.87%223.29M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

The Novo Nordisk A/S (NVO) forecast collects the published price target, analyst ratings, and earnings estimates when they are available.

Forecasts are third-party estimates and often wrong. They are not investment advice.

NVO price target

A low, average, and high target are shown in the tool when analysts have published them.

Is Novo Nordisk A/S a buy or sell?

A Buy, Hold, and Sell split is shown when analysts have published ratings. It is not a recommendation.

Novo Nordisk A/S earnings and revenue forecast

EPS and revenue estimates for the coming years are drawn in the chart when analysts have published them.

NVO score and fair value

The Stocklytics Score, when it is published for NVO, averages value, quality, and growth on a 0–100 scale. It is not a price target. Fair value is a separate estimate on the fair value tab.

NVO forecast FAQs

What is the NVO price target?

A 12-month average target is shown on this page when analysts have published one.

Is Novo Nordisk A/S a buy or sell?

A consensus is shown when analysts have published ratings. It is not a recommendation.

What is the Novo Nordisk A/S stock forecast for 2026?

An EPS estimate for 2026 is shown in the chart on this page when analysts have published one.

What will NVO be worth in 2030?

No reliable forecast exists that far out.

When is Novo Nordisk A/S's next earnings report?

The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.

Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.

Novo Nordisk A/S (NVO) Stock Forecast & Price Target

NVO$38.16-0.51 -1.32%

$168.36B

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History